This trial is active, not recruiting.

Condition breast cancer
Sponsor University of California, Irvine
Collaborator Mentor Worldwide, LLC
Start date January 2000
End date January 2025
Trial size 20 participants
Trial identifier NCT00585884, 2000-1383


Following placement of silicone breast prosthetics for reconstruction

United States No locations recruiting
Other countries No locations recruiting

Study Design

Time perspective prospective

Eligibility Criteria

Female participants of any age.

Inclusion Criteria: - Women undergoing breast surgery Exclusion Criteria: - Collagen vascular disease, Scleroderma

Additional Information

Official title Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Gel-filled Mammary Prostheses in Patients Who Are Undergoing Primary Breast Reconstruction or Revision
Description Patients undergoing breast reconstruction will be followed for outcomes after placement of silicone prostheses
Trial information was received from ClinicalTrials.gov and was last updated in February 2013.
Information provided to ClinicalTrials.gov by University of California, Irvine.